Halozyme Therapeutics Competitors and Similar CompaniesClear all

Karyopharm Therapeutics's competitors and similar companies include Blueprint Medicines and Agenus.

	Karyopharm Therapeutics Karyopharm Therapeutics is a commercial-stage pharmaceutical company that pioneers in cancer therapies.	Blueprint Medicines Blueprint Medicines is a precision therapy company that invents medicines for people with cancer and blood disorders.	Agenus Agenus is an immuno-oncology company that focuses on the discovery and development of therapies for treating cancer.
Founding Date	Founding Date 2008	Founding Date 2011	Founding Date 1994
Type	Type Public	Type Public	Type Public
Tags	Tags Healthcare drug development healthtech pharma	Tags Healthcare drug development life sciences oncology	Tags Healthcare biotech clinical research drug development oncology pharma
Locations	Locations Newton, US HQ Givatayim, IL	Locations Cambridge, US HQ Amsterdam, NL Lugano, CH Zug, CH	Locations Lexington, US HQ Cambridge, GB Emeryville, US Berkeley, US Vacaville, US
Employees	Employees 32516% decrease	Employees 6552% increase	Employees 38927% decrease
Valuation ($)	Valuation ($) 111.7 m	Valuation ($) 5.3 b	Valuation ($) 96.2 m
Financial
Revenue (est.)	Revenue (est.) $145.2m (FY, 2024)	Revenue (est.) $508.8m (FY, 2024)	Revenue (est.) $103.5m (FY, 2024)
Cost of goods	Cost of goods N/A	Cost of goods $20.2m (FY, 2024)	Cost of goods $486k (FY, 2024)
Gross profit	Gross profit N/A	Gross profit $488.7m (FY, 2024)	Gross profit $103m (FY, 2024)
Net income	Net income ($76.4m) (FY, 2024)	Net income ($67.1m) (FY, 2024)	Net income ($232.3m) (FY, 2024)
Funding
Total funding raised	Total funding raised $ 248.7m	Total funding raised $ 1.7b	Total funding raised $ 171.1m